CONMED CORPORATION Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent
CONMED CORPORATION (CNMD) reported Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent of -$1.39 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-25.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent · last filed 2013-02-25
- CONMED CORPORATION other comprehensive (income) loss, defined benefit plan, before tax, after reclassification adjustment, attributable to parent for fiscal 2012 was -$1.39M, a 106.85% decline from fiscal 2011.
- CONMED CORPORATION other comprehensive (income) loss, defined benefit plan, before tax, after reclassification adjustment, attributable to parent for fiscal 2011 was $20.25M, a 480.40% increase from fiscal 2010.
- CONMED CORPORATION other comprehensive (income) loss, defined benefit plan, before tax, after reclassification adjustment, attributable to parent for fiscal 2010 was $3.49M.
| Period end | Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent 12 month |
|---|---|
| 2012-12-31 | -$1.39M 10-K · filed 2013-02-25 |
| 2011-12-31 | $20.25M 10-K · filed 2013-02-25 |
| 2010-12-31 | $3.49M 10-K · filed 2013-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |